In order to further investigate the role of WISP1 polymorphisms in the chemotherapy toxicity of lung cancer, we selected 28 SNPs of the WISP1 gene and genotyped in lung cancer patients to explore the association between WISP1 polymorphisms and platinum-based chemotherapy toxicity. This evidence concerns the gene CCN4 and lung cancer.